In 2004, drug user representatives lobbied against the now stalled $17.5m Australian government Retractable Needle and Syringe Technology Initiative due to concerns about inadequate consultation and potential health risks to participants. 1 Some drug user orga- nisations have also recently withdrawn support for the Australian Illicit Drug Reporting System (conducted annually since 1997), fearing findings that inform drug market disruption by law enforcement in some jurisdictions might increase harms to participants.
No takes yet. Share an insight, caveat, or question.
Fry et al. (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: